Receipt of long-acting injectable antiretroviral therapy among people with HIV in Southern US states: an assessment using electronic health records and claims data

Abstract Background In January 2021, the United States (US) Food and Drug Administration (FDA) approved the first long-acting injectable antiretroviral therapy (LAI ART) regimen for the treatment of HIV providing an alternative to daily oral regimens. We analyzed electronic health records (EHRs) to...

Полное описание

Библиографические подробности

Главные авторы:	Yiyang Liu, Rebecca J. Fisk-Hoffman, Maitri Patel, Robert L. Cook, Mattia Prosperi
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2025-02-01
Серии:	AIDS Research and Therapy
Предметы:	HIV Long-acting antiretroviral therapy Electronic health records Cabotegravir/Rilpivirine
Online-ссылка:	https://doi.org/10.1186/s12981-024-00690-9
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!